📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. (2017)

First Author: Imamura K

Attributed to: MRC Centre for Regenerative Medicine funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.aaf3962

PubMed Identifier: 28539470

Publication URI: http://europepmc.org/abstract/MED/28539470

Type: Journal Article/Review

Volume: 9

Parent Publication: Science translational medicine

Issue: 391

ISSN: 1946-6234